Uncommon Cents Investing LLC Increases Stock Position in Fresenius Medical Care AG (NYSE:FMS)

Uncommon Cents Investing LLC grew its position in shares of Fresenius Medical Care AG (NYSE:FMS) by 8.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 38,810 shares of the company’s stock after purchasing an additional 2,890 shares during the period. Uncommon Cents Investing LLC’s holdings in Fresenius Medical Care were worth $748,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the company. GAMMA Investing LLC increased its stake in Fresenius Medical Care by 21.8% in the 1st quarter. GAMMA Investing LLC now owns 4,230 shares of the company’s stock worth $82,000 after acquiring an additional 758 shares during the last quarter. Hartford Financial Management Inc. grew its holdings in shares of Fresenius Medical Care by 98.8% in the fourth quarter. Hartford Financial Management Inc. now owns 1,688 shares of the company’s stock valued at $35,000 after purchasing an additional 839 shares in the last quarter. Raymond James & Associates increased its position in Fresenius Medical Care by 4.0% in the fourth quarter. Raymond James & Associates now owns 28,960 shares of the company’s stock worth $603,000 after purchasing an additional 1,125 shares during the last quarter. Bruce G. Allen Investments LLC purchased a new stake in Fresenius Medical Care during the fourth quarter valued at $31,000. Finally, Cerity Partners LLC lifted its position in Fresenius Medical Care by 6.1% during the fourth quarter. Cerity Partners LLC now owns 26,786 shares of the company’s stock valued at $558,000 after purchasing an additional 1,545 shares during the last quarter. 8.25% of the stock is owned by institutional investors.

Fresenius Medical Care Trading Up 0.4 %

NYSE:FMS traded up $0.07 during mid-day trading on Thursday, hitting $19.23. 104,869 shares of the stock traded hands, compared to its average volume of 357,919. The company has a quick ratio of 1.14, a current ratio of 1.50 and a debt-to-equity ratio of 0.46. Fresenius Medical Care AG has a 52 week low of $16.37 and a 52 week high of $27.72. The stock has a market capitalization of $11.28 billion, a price-to-earnings ratio of 21.61, a PEG ratio of 1.02 and a beta of 0.90. The firm’s 50 day moving average is $20.72 and its two-hundred day moving average is $20.15.

Fresenius Medical Care (NYSE:FMS) last released its earnings results on Tuesday, May 7th. The company reported $0.36 EPS for the quarter, beating analysts’ consensus estimates of $0.26 by $0.10. Fresenius Medical Care had a return on equity of 5.29% and a net margin of 2.48%. The firm had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.15 billion. On average, equities research analysts predict that Fresenius Medical Care AG will post 1.5 earnings per share for the current year.

Fresenius Medical Care Cuts Dividend

The firm also recently announced an annual dividend, which was paid on Monday, June 3rd. Shareholders of record on Monday, May 20th were paid a $0.437 dividend. The ex-dividend date of this dividend was Friday, May 17th. This represents a yield of 2.35%. Fresenius Medical Care’s payout ratio is 49.44%.

Wall Street Analyst Weigh In

Several research analysts recently commented on the company. Truist Financial lifted their price target on Fresenius Medical Care from $21.00 to $24.00 and gave the stock a “hold” rating in a research report on Wednesday, May 15th. StockNews.com initiated coverage on Fresenius Medical Care in a report on Wednesday. They issued a “strong-buy” rating for the company. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, two have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $32.25.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.